Aug 23 2024 This Week in Cardiology

Aug 23 2024 This Week in Cardiology

Suicidal ideation and GLP-1 agonists, a repeat of PARADIGM HF in Chagas CM, CASTLE HTx critical appraisal, and primary prevention of SCD in HF are the topics John Mandrola, MD, covers this week.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Suicidal ideation with GLP-1

Signal of Suicidality With GLP-1 RA Semaglutide, but Experts Urge Caution

https://www.medscape.com/viewarticle/signal-suicidality-glp-1-ra-semaglutide-experts-urge-caution-2024a1000fa7

  • Disproportionality Analysis from World Health Organization Data on Semaglutide, Liraglutide, and Suicidality
  • Variability in Disproportionality paper https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.668765/full

II. PARACHUTE HF: Repeating the Mistakes in PARADIGM HF

  • PARACHUTE HF https://www.jacc.org/doi/10.1016/j.jchf.2024.05.021
  • SOLVD https://www.nejm.org/doi/full/10.1056/NEJM199108013250501
  • CONSENSUS trial https://www.nejm.org/doi/full/10.1056/NEJM198706043162301
  • Meta-analysis of Low vs High Dose ACE/ARB https://doi.org/10.1161/CIRCHEARTFAILURE.117.003956
  • Meta-analysis of Sac/Val vs ARB/ACE Inhibitors https://link.springer.com/article/10.1007/s00228-024-03686-6
  • PARADISE MI https://www.nejm.org/doi/full/10.1056/NEJMoa2104508

III. CASTLE HTx Critical Appraisal

  • Critical Appraisal of CASTLE HTx https://doi.org/10.1016/j.jacc.2024.06.020
  • CASTLE HTx https://www.nejm.org/doi/10.1056/NEJMoa2306037
  • CASTLE AF https://www.nejm.org/doi/full/10.1056/NEJMoa1707855

IV. More Data Suggesting Modest Benefits of the Primary Prevention ICD

  • First and Recurrent ICD Shocks: JICE Paper from Denmark https://link.springer.com/article/10.1007/s10840-024-01873-0
  • HF trialists https://www.nejm.org/doi/full/10.1056/NEJMoa1609758
    PROFID Trial https://profid-project.eu/
  • DANISH https://www.nejm.org/doi/full/10.1056/NEJMoa1608029
  • SCD-HeFT https://www.nejm.org/doi/full/10.1056/NEJMoa043399

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(402)

Dec 08 2023 This Week in Cardiology

Dec 08 2023 This Week in Cardiology

Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare prof...

8 Des 202328min

Dec 01 2023 This Week in Cardiology

Dec 01 2023 This Week in Cardiology

More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week's podcast...

1 Des 202327min

Nov 17 2023 This Week in Cardiology

Nov 17 2023 This Week in Cardiology

An AHA Recap: SELECT, ORBITA2, and ARTESIA are the trials John Mandrola, MD, reviews in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or...

17 Nov 202325min

Nov 10 2023 This Week in Cardiology

Nov 10 2023 This Week in Cardiology

Renal denervation, a potential deadly decision in the ED, GLP-1 agonists, and an AHA preview are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare...

10 Nov 202324min

Nov 03 2023 This Week in Cardiology

Nov 03 2023 This Week in Cardiology

Tricuspid regurgitation therapy, two more left atrial appendage trials, and reflections on being too soft on medical science are the topics John Mandrola, MD, discusses in this week's podcast. This po...

3 Nov 202326min

Oct 27 2023 This Week in Cardiology

Oct 27 2023 This Week in Cardiology

More on the Million Hearts RCT, ENRICH AF, TAVI vs SAVR, the Partner 3 and Evolut-low-risk trials, and myocardial viability are the topics John Mandrola, MD, covers in this week's podcast. This podcas...

27 Okt 202329min

Oct 20 2023 This Week in Cardiology

Oct 20 2023 This Week in Cardiology

Listener feedback, oral anticoagulation in patients with ICH, an example of statistical significance but not clinical significance, and statins and diabetes are the topics John Mandrola, MD, discusses...

20 Okt 202326min

Oct 13 2023 This Week in Cardiology

Oct 13 2023 This Week in Cardiology

Three stories regarding GLP-1 agonists, imaging during PCI, and the power of sham controls in procedure trials are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended...

13 Okt 202321min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
forskningno
sinnsyn
villmarksliv
rss-paradigmepodden
liberal-halvtime
rss-nysgjerrige-norge
tomprat-med-gunnar-tjomlid
nevropodden
fjellsportpodden
diagnose
tidlose-historier
kvinnehelsepodden
rss-inn-til-kjernen-med-sunniva-rose
psykopoden
dekodet-2
rss-rekommandert